U.S. FDA

FDA Announces Plan to Work with Congress on “New” Path for CBD Products 

The cannabis industry has long-awaited rules from the FDA to guide the CBD industry. Now, it’s up to Congress.

CBD
Newsletter

European cannabis markets are shifting • Some EU member states are dealing with “semi-synthetic cannabinoids” • & more …

An excerpt from recent editions of the Cannabis Wire Daily newsletter.

Newsletter

NYC’s shuttered cannabis sellers file a class action suit • The latest NYC enforcement numbers • & more …

An excerpt from recent editions of the Cannabis Wire Daily newsletter.